TOPLINE In patients with methicillin-susceptible Staphylococcus aureus bacteremia, cefazolin proved noninferior to antistaphylococcal penicillins (flucloxacillin and cloxacillin) for 90-day mortality and was also associated with a lower risk for acute kidney injury. METHODOLOGY Researchers conducted an international, Bayesian adaptive noninferiority trial across eight countries to evaluate the efficacy and safety of cefazolin to treat patients …
Read More
Cefazolin Noninferior to Penicillins for MSSA Bacteremia
